Skip to Content

Tongcheng Earnings: Travel Demand Beyond Prepandemic Levels, With More Robust Growth Expected

""
Securities In This Article
Tongcheng Travel Holdings Ltd
(00780)

We maintain our fair value estimate of HKD 21 for Tongcheng Travel 00780 after it posted better-than-expected second-quarter revenue of CNY 2.86 billion, which was 4% greater than our estimates. The company provided guidance that it should continue to see robust demand for travel into the rest of the year and it expects revenue to grow 57% year on year next quarter. However, we forecast that operating margins could decline slightly by 100-150 basis points in the second half of 2023, due to greater customer acquisition costs that should pressure gross margin by 100 basis points. Tongcheng indicated that it is already seeing elevated demand for Golden Week, sees robust demand into 2024, and can foresee 20%-30% year-on-year revenue growth for 2024. While we are overall encouraged by the robust demand for domestic travel in China, we believe travel stocks may be fairly valued currently, given that we are already expecting travel to surpass the prepandemic level in 2023, given company commentary from the first quarter.

Tongcheng indicated that while demand remained robust, it is also seeing some competition, as it has lowered take rates for its accommodation segment to 8%-8.5% from 9.5% by providing greater subsidies to remain competitive. We believe this is consistent with peers such as Meituan who offer budget hotels, where the company expects a lower operating margin for its hotel platform business. Tongcheng is also responding to competition by preinstalling its app on Huawei phones, which is likely to increase its sales and marketing expenses, which also explains the expected margin decline.

Tongcheng implied that third-quarter year-over-year revenue for the accommodation segment should increase 53%-58% and for transportation, nearly 70% growth. Despite lower accommodation take rates, we expect transportation take rates to remain the same. The company also implied for overall 2023 revenue to increase about 70% year on year.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Kai Wang

Senior Equity Analyst
More from Author

Kai Wang is a senior equity analyst for Morningstar Asia Limited, a wholly owned subsidiary of Morningstar, Inc. He covers ex-Japan internet and healthcare platform and SaaS companies, with a particular focus on China.

Before joining Morningstar, Wang worked at Acuris, where he focused on China energy, tech, and industrial names. He started his career in fixed income in New York before switching over to equity research. He covered energy at Susquehanna and healthcare at Leerink Partners.

Wang has a bachelor's degree in economics from the University of Virginia and a Master of Business Administration from the USC Marshall School of Business.

Sponsor Center